The New Wegovy Tablet Has Been Approved in the UK: Could Weight Loss Finally Become Easier?

The weight loss world has just had some big news.

The MHRA has approved the first oral Wegovy tablet for weight management in the UK, and I think this could be a game changer for many people who have been sitting on the fence about starting treatment.

As someone who has been on my own GLP-1 journey, I understand the emotions that come with making that first decision. For some people it’s fear of side effects. For others it’s the stigma around weight loss medication.

But one concern comes up time and time again:

“I just don’t think I could inject myself.”

Every week at Shape8 we speak to people who are interested in treatment but are nervous about needles. Some have delayed getting help for months, sometimes years, simply because they don’t like the idea of giving themselves an injection.

The approval of an oral Wegovy tablet could remove that barrier completely.

And that’s exciting.

Not because it’s another weight loss product.

But because it gives people more choice.

For too long, weight loss has been treated as a willpower issue. If diets failed, people blamed themselves.

What we now understand is that obesity is a complex medical condition influenced by hormones, appetite regulation, genetics, lifestyle and environment. That’s why treatments such as semaglutide and tirzepatide have changed the conversation around weight management.

The new Wegovy tablet is the next chapter in that story.

What Is the New Wegovy Tablet?

The new Wegovy tablet contains semaglutide, the same active ingredient used in injectable Wegovy.

Like the injectable version, it works by mimicking a natural hormone called GLP-1, helping to:

• Reduce appetite
• Increase feelings of fullness
• Reduce food noise and cravings
• Support sustainable weight loss

The difference is that instead of a weekly injection, it is taken as a tablet once a day.

For many people, that may feel like a much more approachable way to start treatment.

Does It Work As Well As The Injection?

Clinical studies have shown impressive results, with patients achieving significant weight loss when oral semaglutide is combined with lifestyle changes and ongoing support.

In trials for the injectable Wegovy medication, users achieved a reducation in body weight of around 15% on average. When trials were conducted for the Wegovy pill, average weight loss was 13.6%. 

However, there is something important that often gets lost in the headlines.

No medication is a magic solution.

Whether it’s Wegovy, Mounjaro or the new Wegovy tablet, the people who achieve the best long-term results are usually those who also focus on:

• Nutrition
• Physical activity
• Sleep
• Mindset
• Consistency

Medication can help level the playing field, but it works best when combined with healthy habits.

Why Support Matters on a Weight Loss Journey

One of the biggest frustrations I had before founding Shape8 was how lonely weight loss felt.

You filled in a form.

You bought a medication.

The medication arrived.

And that was it.

No support.

No education.

No community.

No one checking in to see how you were doing.

At Shape8, we believe weight loss should be about so much more than simply receiving a prescription.

Our mission has always been to help people build healthier, happier and more confident lives.

That’s why we focus on:

• Education
• Wellness events
• Nutrition support
• Expert guidance
• Long-term lifestyle change

Whether someone chooses injections or tablets, our goal remains exactly the same: helping people create sustainable results that last.

Will Weight Loss Injections Become Obsolete?  

Probably not.

Many people are already doing incredibly well on injectable GLP-1 treatments and may choose to continue with them.

However, the tablet could open the door for thousands of people who have previously avoided treatment because they were nervous about injections.

More choice is always a good thing.

The right treatment is the one that works for you.

When Will the Wegovy Tablet Be Available?

The MHRA has approved the medication, but a confirmed UK launch date has not yet been announced.

We expect further updates over the coming months, and availability is likely to begin through private clinics and pharmacies before any wider NHS rollout.

As soon as we know more, we’ll be keeping our Shape8 community updated.

Frequently Asked Questions

Is the Wegovy tablet available in the UK?

The Wegovy tablet has now been approved by the MHRA, but it is not yet widely available. Availability is expected later in 2026.

How is the Wegovy tablet different from the injection?

The tablet contains the same active ingredient, semaglutide, but is taken daily rather than as a weekly injection.

Is the Wegovy tablet better than Mounjaro?

Both medications can be effective. The most appropriate treatment depends on the individual, their medical history and their personal preferences.

Can I switch from Wegovy injections to tablets?

Potentially, yes. Prescribing guidance will become clearer once the tablet is launched in the UK.

My Final Thoughts

As someone who understands the challenges of weight loss first-hand, I genuinely believe this is an exciting step forward.

For years, many people have struggled in silence, trying every diet imaginable and blaming themselves when nothing worked.

We now understand obesity far better than we ever have before.

Weight management isn’t simply about willpower.

It’s about biology, hormones, support and having access to the right tools.

The approval of the Wegovy tablet gives people another option, another opportunity and another reason to believe that change is possible.

And that’s something worth celebrating.

Mandy Sandhu
Co-Founder, Shape8